Marianne Goodman1, David Carpenter2, Cheuk Y Tang2, Kim E Goldstein3, Jennifer Avedon4, Nicolas Fernandez4, Kathryn A Mascitelli4, Nicholas J Blair4, Antonia S New5, Joseph Triebwasser6, Larry J Siever7, Erin A Hazlett5. 1. Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA; VISN 3 Mental Illness Research, Education, and Clinical Center (MIRECC), James J. Peters VA Medical Center, Bronx, NY, USA; Oupatient Psychiatry, James J. Peters VA Medical Center, Bronx, NY, USA. Electronic address: marianne.goodman@va.gov. 2. Department of Radiology, Icahn School of Medicine at Mount Sinai, USA. 3. Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA. 4. VISN 3 Mental Illness Research, Education, and Clinical Center (MIRECC), James J. Peters VA Medical Center, Bronx, NY, USA. 5. Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA; VISN 3 Mental Illness Research, Education, and Clinical Center (MIRECC), James J. Peters VA Medical Center, Bronx, NY, USA. 6. Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Oupatient Psychiatry, James J. Peters VA Medical Center, Bronx, NY, USA. 7. Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA; VISN 3 Mental Illness Research, Education, and Clinical Center (MIRECC), James J. Peters VA Medical Center, Bronx, NY, USA; Oupatient Psychiatry, James J. Peters VA Medical Center, Bronx, NY, USA.
Abstract
OBJECTIVE: Siever and Davis' (1991) psychobiological framework of borderline personality disorder (BPD) identifies affective instability (AI) as a core dimension characterized by prolonged and intense emotional reactivity. Recently, deficient amygdala habituation, defined as a change in response to repeated relative to novel unpleasant pictures within a session, has emerged as a biological correlate of AI in BPD. Dialectical behavior therapy (DBT), an evidence-based treatment, targets AI by teaching emotion-regulation skills. This study tested the hypothesis that BPD patients would exhibit decreased amygdala activation and improved habituation, as well as improved emotion regulation with standard 12-month DBT. METHODS: Event-related fMRI was obtained pre- and post-12-months of standard-DBT in unmedicated BPD patients. Healthy controls (HCs) were studied as a benchmark for normal amygdala activity and change over time (n = 11 per diagnostic-group). During each scan, participants viewed an intermixed series of unpleasant, neutral and pleasant pictures presented twice (novel, repeat). Change in emotion regulation was measured with the Difficulty in Emotion Regulation (DERS) scale. RESULTS: fMRI results showed the predicted Group × Time interaction: compared with HCs, BPD patients exhibited decreased amygdala activation with treatment. This post-treatment amygdala reduction in BPD was observed for all three pictures types, but particularly marked in the left hemisphere and during repeated-emotional pictures. Emotion regulation measured with the DERS significantly improved with DBT in BPD patients. Improved amygdala habituation to repeated-unpleasant pictures in patients was associated with improved overall emotional regulation measured by the DERS (total score and emotion regulation strategy use subscale). CONCLUSION: These findings have promising treatment implications and support the notion that DBT targets amygdala hyperactivity-part of the disturbed neural circuitry underlying emotional dysregulation in BPD. Future work includes examining how DBT-induced amygdala changes interact with frontal-lobe regions implicated in emotion regulation. Published by Elsevier Ltd.
OBJECTIVE: Siever and Davis' (1991) psychobiological framework of borderline personality disorder (BPD) identifies affective instability (AI) as a core dimension characterized by prolonged and intense emotional reactivity. Recently, deficient amygdala habituation, defined as a change in response to repeated relative to novel unpleasant pictures within a session, has emerged as a biological correlate of AI in BPD. Dialectical behavior therapy (DBT), an evidence-based treatment, targets AI by teaching emotion-regulation skills. This study tested the hypothesis that BPD patients would exhibit decreased amygdala activation and improved habituation, as well as improved emotion regulation with standard 12-month DBT. METHODS: Event-related fMRI was obtained pre- and post-12-months of standard-DBT in unmedicated BPD patients. Healthy controls (HCs) were studied as a benchmark for normal amygdala activity and change over time (n = 11 per diagnostic-group). During each scan, participants viewed an intermixed series of unpleasant, neutral and pleasant pictures presented twice (novel, repeat). Change in emotion regulation was measured with the Difficulty in Emotion Regulation (DERS) scale. RESULTS: fMRI results showed the predicted Group × Time interaction: compared with HCs, BPD patients exhibited decreased amygdala activation with treatment. This post-treatment amygdala reduction in BPD was observed for all three pictures types, but particularly marked in the left hemisphere and during repeated-emotional pictures. Emotion regulation measured with the DERS significantly improved with DBT in BPD patients. Improved amygdala habituation to repeated-unpleasant pictures in patients was associated with improved overall emotional regulation measured by the DERS (total score and emotion regulation strategy use subscale). CONCLUSION: These findings have promising treatment implications and support the notion that DBT targets amygdala hyperactivity-part of the disturbed neural circuitry underlying emotional dysregulation in BPD. Future work includes examining how DBT-induced amygdala changes interact with frontal-lobe regions implicated in emotion regulation. Published by Elsevier Ltd.
Authors: Claudia P de-Almeida; Amy Wenzel; Camila S de-Carvalho; Vania B Powell; César Araújo-Neto; Lucas C Quarantini; Irismar R de-Oliveira Journal: CNS Spectr Date: 2012-06 Impact factor: 3.790
Authors: Stephen M Smith; Mark Jenkinson; Mark W Woolrich; Christian F Beckmann; Timothy E J Behrens; Heidi Johansen-Berg; Peter R Bannister; Marilena De Luca; Ivana Drobnjak; David E Flitney; Rami K Niazy; James Saunders; John Vickers; Yongyue Zhang; Nicola De Stefano; J Michael Brady; Paul M Matthews Journal: Neuroimage Date: 2004 Impact factor: 6.556
Authors: Harold W Koenigsberg; Larry J Siever; Hedok Lee; Scott Pizzarello; Antonia S New; Marianne Goodman; Hu Cheng; Janine Flory; Isak Prohovnik Journal: Psychiatry Res Date: 2009-04-24 Impact factor: 3.222
Authors: Nelson H Donegan; Charles A Sanislow; Hilary P Blumberg; Robert K Fulbright; Cheryl Lacadie; Pawel Skudlarski; John C Gore; Ingrid R Olson; Thomas H McGlashan; Bruce E Wexler Journal: Biol Psychiatry Date: 2003-12-01 Impact factor: 13.382
Authors: Anna Buchheim; Roberto Viviani; Henrik Kessler; Horst Kächele; Manfred Cierpka; Gerhard Roth; Carol George; Otto F Kernberg; Georg Bruns; Svenja Taubner Journal: PLoS One Date: 2012-03-28 Impact factor: 3.240
Authors: David L Perez; David R Vago; Hong Pan; James Root; Oliver Tuescher; Benjamin H Fuchs; Lorene Leung; Jane Epstein; Nicole M Cain; John F Clarkin; Mark F Lenzenweger; Otto F Kernberg; Kenneth N Levy; David A Silbersweig; Emily Stern Journal: Psychiatry Clin Neurosci Date: 2015-10-08 Impact factor: 5.188